Abstract
The annual American Society of Clinical Oncology congress is the largest forum for cancer professionals in the world, promoting new developments in cancer medicine. A wide spectrum of subjects relevant to breast cancer research and treatment was covered in this year's meeting, including chemotherapy in the neoadjuvant and adjuvant settings, molecular and gene profiling studies, and use of more conventional prognostic and predictive markers of outcome. This report discusses some of the highlights in translational and clinical aspects of early breast cancer management presented at the meeting.
Publication types
-
Congress
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Biomarkers, Tumor / analysis*
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / genetics
-
Breast Neoplasms / metabolism*
-
Cell Cycle Proteins / analysis
-
Chemotherapy, Adjuvant
-
Cyclin-Dependent Kinase Inhibitor p27
-
Gene Expression Regulation, Neoplastic / drug effects
-
Predictive Value of Tests
-
Prognosis
-
Tumor Suppressor Proteins / analysis
Substances
-
Biomarkers, Tumor
-
Cell Cycle Proteins
-
Tumor Suppressor Proteins
-
Cyclin-Dependent Kinase Inhibitor p27